$SATT
SATIVUS TECH CORP. Stock $satt

$satt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023084295 Filed on November 07, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$150.0K	$107.0K	$170.0K
YoY Change	-11.76%	-43.39%	-65.16%
% of Gross Profit
Research & Development	-$48.00K	$161.0K	$179.0K
YoY Change	-126.82%	-26.15%	-61.75%
% of Gross Profit
Depreciation & Amortization	$21.00K	$29.00K	$2.000K
YoY Change	950.0%	222.22%	-60.0%
% of Gross Profit
Operating Expenses	$102.0K	$161.0K	$349.0K
YoY Change	-70.77%	-26.15%	-63.49%
Operating Profit		-$268.0K
YoY Change		-34.15%
Interest Expense	-$152.0K	$1.252M	-$363.0K
YoY Change	-58.13%	-387.82%	611.76%
% of Operating Profit
Other Income/Expense, Net		$1.252M
YoY Change		-387.82%
Pretax Income	-$254.0K	$984.0K	-$712.0K
YoY Change	-64.33%	-216.86%	-29.29%
Income Tax
% Of Pretax Income
Net Earnings	-$224.0K	$1.082M	-$631.0K
YoY Change	-64.5%	-228.5%	-23.98%
Net Earnings / Revenue
Basic Earnings Per Share		$0.26
Diluted Earnings Per Share	-$0.05	$0.22	-$0.15
COMMON SHARES
Basic Shares Outstanding	4.216M shares	4.216M shares	4.194M shares
Diluted Shares Outstanding		4.820M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$813.0K	$1.157M	$810.0K
YoY Change	0.37%	505.76%	-6.47%
Cash & Equivalents	$176.0K	$425.0K	$810.0K
Short-Term Investments	$637.0K	$732.0K
Other Short-Term Assets	$313.0K	$34.00K	$85.00K
YoY Change	268.24%	-15.0%	10.39%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$313.0K
Total Short-Term Assets	$1.137M	$1.191M	$901.0K
YoY Change	26.19%	392.15%	-6.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$256.0K	$240.0K	$219.0K
YoY Change	16.89%	14.83%	3550.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$271.0K	$259.0K	$249.0K
YoY Change	8.84%	6.58%	378.85%
TOTAL ASSETS
Total Short-Term Assets	$1.137M	$1.191M	$901.0K
Total Long-Term Assets	$271.0K	$259.0K	$249.0K
Total Assets	$1.408M	$1.450M	$1.150M
YoY Change	22.43%	198.97%	13.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.00K	$10.00K	$55.00K
YoY Change	-16.36%	-69.7%	358.33%
Accrued Expenses	$13.00K	$12.00K	$32.00K
YoY Change	-59.38%	-20.0%	60.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.074M	$2.032M	$2.145M
YoY Change	-3.31%	-6.62%	-28.36%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.130M	$2.935M	$3.719M
YoY Change	-15.84%	-19.3%	10.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.130M	$2.935M	$3.719M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$3.130M	$2.935M	$3.719M
YoY Change	-15.84%	-19.74%	9.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.93M	-$22.70M	-$22.60M
YoY Change	1.43%	3.33%	7.24%
Common Stock	$20.64M	$20.64M	$4.000K
YoY Change	516000.0%	515950.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.284M	-$2.062M	-$2.844M
YoY Change
Total Liabilities & Shareholders Equity	$1.408M	$1.450M	$1.150M
YoY Change	22.43%	198.97%	13.3%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$224.0K	$1.082M	-$631.0K
YoY Change	-64.5%	-228.5%	-23.98%
Depreciation, Depletion And Amortization	$21.00K	$29.00K	$2.000K
YoY Change	950.0%	222.22%	-60.0%
Cash From Operating Activities	-$302.0K	-$213.0K	-$253.0K
YoY Change	19.37%	-10.88%	427.08%
INVESTING ACTIVITIES
Capital Expenditures	$31.00K	$22.00K	$7.000K
YoY Change	342.86%		40.0%
Acquisitions
YoY Change
Other Investing Activities	$84.00K	-$726.0K	$5.000K
YoY Change	1580.0%		-600.0%
Cash From Investing Activities	$53.00K	-$748.0K	-$2.000K
YoY Change	-2750.0%		-150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-14.00K	874.0K
YoY Change	-100.0%	-104.86%	-14666.67%
NET CHANGE
Cash From Operating Activities	-302.0K	-213.0K	-253.0K
Cash From Investing Activities	53.00K	-748.0K	-2.000K
Cash From Financing Activities	0.000	-14.00K	874.0K
Net Change In Cash	-249.0K	-975.0K	619.0K
YoY Change	-140.23%	-2089.8%	-1338.0%
FREE CASH FLOW
Cash From Operating Activities	-$302.0K	-$213.0K	-$253.0K
Capital Expenditures	$31.00K	$22.00K	$7.000K
Free Cash Flow	-$333.0K	-$235.0K	-$260.0K
YoY Change	28.08%	-1.67%	390.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-208814
	dei	Entity Registrant Name EntityRegistrantName	SATIVUS TECH CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2847446
	dei	Entity Address Address Line1 EntityAddressAddressLine1	#3 Bethesda Metro Center
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#700
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06880
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	608-6432
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4215571	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	425000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	810000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	732000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	6000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	34000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	85000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1191000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	901000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	240000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	219000	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	259000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	249000	usd
CY2023Q3	us-gaap	Assets Assets	1450000	usd
CY2022Q4	us-gaap	Assets Assets	1150000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	55000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	114000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	160000	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2032000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2031000	usd
CY2023Q3	satt	Fair Value Of Convertible Component In Convertible Loan FairValueOfConvertibleComponentInConvertibleLoan	762000	usd
CY2022Q4	satt	Fair Value Of Convertible Component In Convertible Loan FairValueOfConvertibleComponentInConvertibleLoan	1327000	usd
CY2023Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	12000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	32000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2935000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3719000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4215571	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4215571	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4215571	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4215571	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20638000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19756000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22704000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22604000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2062000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2844000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	577000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	275000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1485000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2569000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1450000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1150000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	161000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	218000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	301000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	494000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	189000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	412000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	490000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-268000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-407000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-713000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-984000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1252000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-435000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	380000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-117000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	984000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-842000	usd
	us-gaap	Profit Loss ProfitLoss	-333000	usd
	us-gaap	Profit Loss ProfitLoss	-1101000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-98000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-110000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-233000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-205000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1082000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-732000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-896000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4215571	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4215571	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4194385	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4820442	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4194385	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4215571	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4194385	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2372000	usd
CY2022Q1	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	147000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	40000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	211000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	421000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1975000	usd
CY2022Q2	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	127000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-680000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2493000	usd
CY2022Q3	satt	Stock Issued During Period Value Transactions With Noncontrolling Parties StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties	100000	usd
CY2022Q3	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	50000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-842000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3172000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2569000	usd
CY2023Q1	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	39000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	usd
CY2023Q1	satt	Stock Issued During Period Value Transactions With Noncontrolling Parties StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties	1274000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-316000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1537000	usd
CY2023Q2	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	26000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	14000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2490000	usd
CY2023Q3	satt	Share Based Compensation To Employees And Nonemployee ShareBasedCompensationToEmployeesAndNonemployee	19000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	984000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1485000	usd
	us-gaap	Profit Loss ProfitLoss	-333000	usd
	us-gaap	Profit Loss ProfitLoss	-1101000	usd
	us-gaap	Depreciation Depreciation	39000	usd
	us-gaap	Depreciation Depreciation	36000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	142000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	172000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	122000	usd
	satt	Financial Expenses Related To Loans From Related Party FinancialExpensesRelatedToLoansFromRelatedParty	-980000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	-565000	usd
	satt	Change In Fair Value Of Convertible Component In Convertible Loan ChangeInFairValueOfConvertibleComponentInConvertibleLoan	1081000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-51000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-37000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-45000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	21000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-41000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-630000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-733000	usd
	satt	Increases In Restricted Cash IncreasesInRestrictedCash	726000	usd
	satt	Increases In Restricted Cash IncreasesInRestrictedCash	-9000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	199000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-774000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-190000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	239000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	126000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	75000	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-114000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1273000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1019000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-385000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-675000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	810000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	866000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	425000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191000	usd
	us-gaap	Interest Paid Net InterestPaidNet	75000	usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital	28000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22704000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-630000	usd
CY2023Q3	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	762000	usd
CY2023Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	762000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	1327000	usd
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1327000	usd
CY2019Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	550000	usd
CY2019Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	326000	usd
CY2021Q2	us-gaap	Debt Current DebtCurrent	14000	usd
CY2022Q1	us-gaap	Debt Current DebtCurrent	20000	usd
CY2020Q3	us-gaap	Employee Stock Ownership Plan Esop Debt Structure Direct Loan Employer Cash Payments Used For Debt Service EmployeeStockOwnershipPlanESOPDebtStructureDirectLoanEmployerCashPaymentsUsedForDebtService	100000	usd
CY2020Q3	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.10	pure
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	18000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	129000	usd
	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	82000	usd
CY2022	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	88000	usd
CY2022Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36000	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	277000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	29000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	306000	usd
CY2023Q3	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	127000	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	182000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	8000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	190000	usd
CY2022Q3	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	153000	usd
	satt	Schedule Of Warrant Activity ScheduleOfWarrantActivity	A summary of warrant activity during the nine months period ended September 30, 2023, and year ended December 31, 2022 is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-indent: -9pt; padding-left: 9pt">Warrants outstanding at January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">198,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Warrants outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Warrants outstanding at September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">119,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.88</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	198750	shares
CY2021Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	5.4
CY2022	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled	-13750	shares
CY2022	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled	2
CY2022	satt	Number Warrants Forfeited Cancelled NumberWarrantsForfeitedCancelled	-66000	shares
CY2022	satt	Average Exercise Prices Forfeited Cancelled AverageExercisePricesForfeitedCancelled	1.5
CY2022Q4	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	119000	shares
CY2022Q4	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	5.88
CY2023Q3	satt	Number Of Warrant Outstanding NumberOfWarrantOutstanding	119000	shares
CY2023Q3	satt	Average Exercise Price Warrant Outstanding AverageExercisePriceWarrantOutstanding	5.88
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	119000	shares
CY2022	satt	Class Of Warrant Or Righst Warrants Or Rights Exercisable ClassOfWarrantOrRighstWarrantsOrRightsExercisable	119000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	119000	shares
	satt	Class Of Warrant Or Righst Warrants Or Rights Exercisable ClassOfWarrantOrRighstWarrantsOrRightsExercisable	119000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.63
CY2022	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	45000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	240000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.7
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	240000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.7
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	232500	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	240000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	232500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	196000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	370000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	30000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	536000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	5000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	531000	shares
CY2023Q3	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-1269000	usd
CY2022Q3	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	108000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	-437000	usd
	satt	Financial Expenses Related To Interest And Revaluation FinancialExpensesRelatedToInterestAndRevaluation	100000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-17000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	10000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-57000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-17000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1252000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-98000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	380000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	117000	usd
CY2023Q3	us-gaap	Investment Maturity Date InvestmentMaturityDate	2024-09-11
	us-gaap	Facility Costs FacilityCosts	2000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	23000	usd
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR.
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	535000	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	satt	Purchase Of Fixed Assets By Issuance Of Share Capital PurchaseOfFixedAssetsByIssuanceOfShareCapital		usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees		usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees		usd
CY2022	satt	Number Warrant Granted NumberWarrantGranted		shares
CY2022	satt	Average Exercise Price Warrants Granted AverageExercisePriceWarrantsGranted
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	satt	Number Warrant Forfeited Cancelled NumberWarrantForfeitedCancelled		shares
	satt	Average Exercise Price Forfeited Cancelled AverageExercisePriceForfeitedCancelled
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	satt	Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	satt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised		shares
CY2023Q3	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2022Q3	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
	satt	Expenses Due To Change In Fair Value Of Warrant ExpensesDueToChangeInFairValueOfWarrant		usd
CY2023Q3	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001661600

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
satt-20230930_cal.xml	Edgar Link	unprocessable
0001213900-23-084295-index-headers.html	Edgar Link	pending
0001213900-23-084295-index.html	Edgar Link	pending
0001213900-23-084295.txt	Edgar Link	pending
0001213900-23-084295-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_sativustech.htm	Edgar Link	pending
f10q0923ex31-2_sativustech.htm	Edgar Link	pending
f10q0923ex32-1_sativustech.htm	Edgar Link	pending
f10q0923ex32-2_sativustech.htm	Edgar Link	pending
f10q0923_sativustech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
f10q0923_sativustech_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
satt-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
satt-20230930_def.xml	Edgar Link	unprocessable
satt-20230930_lab.xml	Edgar Link	unprocessable
satt-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SATT
SATIVUS TECH CORP. Stock $satt

2023 Q4 Form 10-Q Financial Statement

#000121390023084295 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT SATIVUS TECH CORP. Stock $satt

2023 Q4 Form 10-Q Financial Statement

#000121390023084295 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SATT
SATIVUS TECH CORP. Stock $satt